Recruiting Interstitial Lung Disease Studies in University Park
About Interstitial Lung Disease Clinical Trials in University Park
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 2 interstitial lung disease clinical trials recruiting participants in University Park, PA. These studies are seeking a combined 680 participants. Research is being sponsored by Penn State University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in University Park — FAQ
Are there interstitial lung disease clinical trials in University Park?
Yes, there are 2 interstitial lung disease clinical trials currently recruiting in University Park, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in University Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the University Park research site will contact you about next steps.
Are clinical trials in University Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many University Park studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 2 active trials in University Park are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov